LOGIN  |  REGISTER
Assertio

List of Healthcare Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 526.72
1.67 0.32
4.22M
920.28M
US$ 484.730B
US$ 427.10
-1.79 -0.42
1.17M
231.92M
US$ 99.050B
US$ 317.67
-4.73 -1.47
1.63M
278.15M
US$ 88.360B
US$ 332.39
0.74 0.22
1.22M
253.30M
US$ 84.190B
US$ 64.41
0.75 1.18
7.96M
1.26B
US$ 81.150B
US$ 214.49
0.81 0.38
850,341
162.35M
US$ 34.820B
US$ 62.36
0.43 0.69
3.53M
504.86M
US$ 31.480B
US$ 253.36
-0.41 -0.16
865,021
120.41M
US$ 30.510B
US$ 61.18
0.67 1.11
5.52M
456.87M
US$ 27.950B
US$ 343.91
-2.80 -0.81
480,558
57.20M
US$ 19.670B
US$ 23.34
-0.59 -2.47
555,852
586.83M
US$ 13.700B
US$ 148.38
-1.11 -0.74
591,257
82.02M
US$ 12.170B
US$ 65.72
-0.48 -0.73
1.31M
172.76M
US$ 11.350B
US$ 119.15
-1.20 -1.00
1.11M
95.10M
US$ 11.330B
US$ 174.48
-0.05 -0.03
489,786
58.71M
US$ 10.240B
US$ 97.49
-0.47 -0.48
659,034
100.75M
US$ 9.820B
US$ 10.71
0.03 0.28
16.89M
864.15M
US$ 9.250B
US$ 577.85
-19.49 -3.26
89,157
14.98M
US$ 8.660B
US$ 126.18
-3.16 -2.44
471,507
57.30M
US$ 7.230B
US$ 80.73
1.93 2.45
940,563
86.66M
US$ 7.000B
US$ 52.50
1.26 2.46
1.86M
128.14M
US$ 6.730B
US$ 35.69
0.76 2.18
866,169
172.09M
US$ 6.140B
US$ 14.31
0.00 0.00
0
422.39M
US$ 6.040B
US$ 33.46
-0.08 -0.24
1.21M
170.18M
US$ 5.690B
US$ 18.11
0.00 0.00
1.59M
191.70M
US$ 3.470B
US$ 17.38
0.23 1.34
548,224
174.13M
US$ 3.030B
US$ 92.00
0.11 0.12
217,642
32.75M
US$ 3.010B
US$ 12.62
-0.38 -2.92
3.42M
211.76M
US$ 2.670B
US$ 20.83
-0.29 -1.37
1.07M
127.11M
US$ 2.650B
US$ 21.83
-0.14 -0.64
652,815
120.00M
US$ 2.620B
US$ 26.46
-2.23 -7.77
963,226
92.89M
US$ 2.460B
US$ 6.44
-0.20 -3.01
1.34M
382.64M
US$ 2.460B
US$ 87.70
7.68 9.60
554,137
27.47M
US$ 2.410B
US$ 15.73
-0.08 -0.51
584,981
128.99M
US$ 2.030B
US$ 21.88
-0.73 -3.23
840,573
85.15M
US$ 1.860B
US$ 19.29
-0.15 -0.77
722,976
96.11M
US$ 1.850B
US$ 97.59
-2.29 -2.29
205,795
18.13M
US$ 1.770B
US$ 4.17
0.02 0.36
2.06M
412.02M
US$ 1.720B
US$ 11.98
-0.22 -1.80
180,475
142.73M
US$ 1.710B
US$ 9.29
-0.26 -2.72
1.39M
160.99M
US$ 1.500B
US$ 9.62
0.08 0.84
373,347
155.18M
US$ 1.490B
US$ 31.66
-1.03 -3.15
364,599
46.32M
US$ 1.470B
US$ 91.88
-1.01 -1.09
30,604
15.44M
US$ 1.420B
US$ 23.80
-0.51 -2.10
351,409
58.12M
US$ 1.380B
US$ 29.86
-0.21 -0.70
211,399
45.65M
US$ 1.360B
US$ 3.23
-0.10 -3.00
8.24M
412.08M
US$ 1.330B
US$ 20.93
-0.32 -1.51
57,317
63.29M
US$ 1.320B
US$ 7.11
-0.18 -2.47
6.63M
172.17M
US$ 1.220B
US$ 18.18
0.15 0.83
646,322
63.69M
US$ 1.160B
US$ 5.70
-0.11 -1.89
2.21M
199.21M
US$ 1.140B
US$ 13.24
-0.27 -2.00
444,896
85.88M
US$ 1.140B
US$ 9.54
-0.45 -4.50
1.22M
115.03M
US$ 1.100B
C$ 4.17
0.07 1.71
922,754
248.96M
C$ 1.040B
US$ 64.72
-2.38 -3.55
110,272
15.10M
US$ 977.270M
US$ 4.94
-0.09 -1.79
364,997
193.22M
US$ 954.510M
US$ 30.83
-0.43 -1.38
101,984
30.41M
US$ 937.540M
US$ 24.37
-0.21 -0.85
119,275
34.35M
US$ 836.940M
US$ 7.39
-0.08 -1.07
2.04M
107.00M
US$ 790.730M
US$ 19.53
-0.86 -4.22
576,545
38.07M
US$ 743.320M
US$ 9.87
-0.20 -1.99
312,552
73.29M
US$ 723.370M
US$ 7.02
0.12 1.74
3.16M
81.68M
US$ 572.990M
US$ 1.43
0.00 0.00
0
371.88M
US$ 531.790M
US$ 24.69
-0.99 -3.86
192,113
20.09M
US$ 496.020M
C$ 9.36
-0.24 -2.50
72,062
52.61M
C$ 492.430M
US$ 29.20
0.00 0.00
0
16.17M
US$ 472.160M
US$ 2.64
0.01 0.38
1.35M
168.92M
US$ 445.950M
US$ 4.00
-2.81 -41.26
140,374
107.64M
US$ 430.560M
US$ 4.07
-0.05 -1.21
1.14M
104.27M
US$ 424.380M
US$ 75.00
3.63 5.09
56,673
5.44M
US$ 408.000M
US$ 7.97
-0.18 -2.21
222,925
50.28M
US$ 400.730M
US$ 20.95
-0.79 -3.63
26,360
19.07M
US$ 399.520M
US$ 2.89
0.06 2.16
18,487
135.46M
US$ 391.610M
US$ 25.23
-0.27 -1.06
137,839
14.93M
US$ 376.610M
C$ 15.07
-0.19 -1.25
124,106
23.40M
C$ 352.640M
US$ 2.39
-0.06 -2.45
1.91M
138.95M
US$ 332.090M
US$ 15.26
-0.29 -1.86
208,937
20.27M
US$ 309.220M
US$ 2.52
0.005 0.20
986,766
115.52M
US$ 290.530M
US$ 2.57
0.06 2.35
729,025
101.53M
US$ 260.830M
US$ 3.92
-0.09 -2.24
334,753
60.85M
US$ 238.530M
US$ 9.55
8.80 1.00
47,211
23.12M
US$ 220.870M
C$ 1.33
-0.01 -0.75
268,296
165.88M
C$ 220.620M
US$ 6.77
0.02 0.30
2,362
30.00M
US$ 203.100M
US$ 2.82
0.06 2.17
72,092
66.44M
US$ 187.360M
C$ 2.63
-0.02 -0.75
19,400
63.49M
C$ 166.980M
US$ 10.45
-0.25 -2.34
49,221
14.98M
US$ 156.540M
US$ 7.77
0.02 0.26
273,795
18.42M
US$ 143.120M
US$ 5.10
1.11 27.82
400
27.08M
US$ 138.110M
US$ 3.66
-0.16 -4.19
97,676
37.15M
US$ 135.970M
US$ 2.35
0.00 0.00
0
49.43M
US$ 116.160M
US$ 1.52
0.17 12.59
833,280
75.56M
US$ 114.850M
US$ 1.92
-0.06 -3.03
438,216
57.88M
US$ 110.840M
C$ 1.45
-0.10 -6.45
81,727
74.08M
C$ 107.420M
US$ 1.41
0.09 6.82
51,185
73.84M
US$ 104.110M
US$ 3.20
-0.09 -2.74
141,995
31.11M
US$ 99.550M
US$ 6.56
-0.03 -0.46
27,608
13.67M
US$ 89.680M
US$ 0.81
0.01 1.75
57,776
86.02M
US$ 70.020M
US$ 1.93
0.009 0.47
9,740
31.02M
US$ 59.840M
US$ 6.35
0.08 1.28
15,256
8.29M
US$ 52.640M
US$ 6.37
-0.08 -1.24
1,788
8.06M
US$ 51.300M
US$ 1.71
-0.04 -2.29
288,418
26.35M
US$ 45.060M
US$ 1.65
0.07 4.43
29,384
22.41M
US$ 36.980M
US$ 2.02
0.00 0.00
0
16.39M
US$ 33.110M
US$ 1.23
-0.07 -5.38
861
24.67M
US$ 30.340M
US$ 0.17
-0.005 -2.92
872,779
162.86M
US$ 27.030M
C$ 0.24
-0.005 -2.04
7,500
86.21M
C$ 20.690M
US$ 1.25
-0.01 -0.79
598,644
16.26M
US$ 20.320M
US$ 2.83
-0.17 -5.67
11,485
6.42M
US$ 18.170M
US$ 0.21
0.00 0.00
0
82.96M
US$ 17.180M
C$ 0.28
0.00 0.00
23,499
59.14M
C$ 16.560M
US$ 1.11
-0.01 -0.89
206,483
14.28M
US$ 15.850M
US$ 0.48
-0.0026 -0.54
30,321
27.99M
US$ 13.490M
US$ 1.51
0.21 16.31
210,877
8.71M
US$ 13.170M
US$ 4.39
-0.05 -1.13
3,009
2.82M
US$ 12.380M
US$ 0.86
-0.10 -10.42
10,402
14.36M
US$ 12.350M
C$ 0.13
0.00 0.00
0
93.47M
C$ 11.680M
C$ 0.18
0.00 0.00
78,500
56.40M
C$ 10.150M
US$ 1.48
0.00 0.00
134,693
5.98M
US$ 8.850M
US$ 1.92
-0.12 -5.97
6,937
4.27M
US$ 8.200M
C$ 0.05
0.00 0.00
0
133.13M
C$ 6.660M
US$ 0.86
-0.02 -2.11
12,485
7.04M
US$ 6.040M
US$ 1.41
-0.04 -2.87
14,035
4.22M
US$ 5.950M
US$ 2.77
0.00 0.00
0
1.88M
US$ 5.220M
US$ 0.35
0.00 0.00
0
12.75M
US$ 4.460M
US$ 1.62
-0.22 -11.96
142,935
2.49M
US$ 4.030M
US$ 0.89
-0.90 -50.11
109
4.22M
US$ 3.770M
C$ 0.06
0.00 0.00
0
55.51M
C$ 3.330M
US$ 0.21
0.02 13.24
423,582
8.97M
US$ 1.910M
US$ 0.42
0.00 0.00
0
3.81M
US$ 1.610M
C$ 0.21
0.00 0.00
0
6.40M
C$ 1.340M
US$ 0.23
0.01 4.56
353,052
5.67M
US$ 1.330M
US$ 0.68
-0.07 -9.85
59,052
1.86M
US$ 1.260M
C$ 0.02
0.00 0.00
0
47.62M
C$ 952K
C$ 0.01
0.00 0.00
0
89.59M
C$ 896K
US$ 0.28
0.00 0.00
0
3.13M
US$ 876K
C$ 0.01
0.00 0.00
0
87.10M
C$ 871K
C$ 0.005
0.00 0.00
0
173.26M
C$ 866K
US$ 0.01
0.00 0.00
0
37.67M
US$ 377K
US$ 0.00
-0.15 -100.00
5,004
19.73M
US$ -
US$ 0.00
0.00 0.00
0
-
US$ -

Latest Healthcare Stock News


CareCloud to Present at the LD Micro Invitational XV

SOMERSET, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, is pleased to announce its participation in the 15th Annual LD Micro Invitational at the Westin Grand Central Hotel in New York on April 9-10, 2025. The Company is scheduled to present on April 10, 2025 at 3:30 p.m. ET. CareCloud’s... Read more


American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended... Read more


Ardent Health Appoints Robert DeMichiei to Board of Directors

BRENTWOOD, Tenn. / Apr 03, 2025 / Business Wire / Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh... Read more


Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results

Total revenue grew 23% year-over-year driven by strong growth in both software and services Maintains full-year revenue guidance of $90 to $93 million and adjusted diluted EPS of $1.07 to $1.20 RESEARCH TRIANGLE PARK, N.C. / Apr 03, 2025 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma... Read more


NetraMark And Worldwide Clinical Trials Announce Agreement To Transform Clinical Trial Design With AI-Powered Precision

TORONTO, April 3, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced a global agreement with Worldwide Clinical Trials ("Worldwide"), a full-service, global contract research organization (CRO). This strategic partnership introduces... Read more


GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

Focus on Inborn Errors of Immunity expands access to exome and genome testing for the known 200,000+ patients in the US 1 impacted by these conditions and opens new opportunities for GeneDx and biopharma partners to accelerate the path to treatment for patients GAITHERSBURG, Md. / Apr 03, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the commercial expansion into Inborn Errors of... Read more


Aveanna Healthcare Announces Agreement to Acquire Thrive Skilled Pediatric Care

ATLANTA, April 03, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that it has entered into an agreement to acquire Thrive Skilled Pediatric Care ("Thrive SPC"). The transaction is expected to close in the second fiscal quarter of 2025, subject to customary regulatory approvals. Thrive SPC is one of the... Read more


PanGenomic Health Announces Management Change

Vancouver, British Columbia, Canada – TheNewswire - April 3, 2025 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) announces the resignation of Tammy Gillis as CFO of the Company. Ms. Gillis will continue to act as a financial consultant to the Company, and in particular, assist with completion of the year end audit process for the last fiscal year. Current director Francisco Kent Carasquero will assume the role of CFO and remain a director... Read more


CareCloud Acquires RevNu Medical Management, Completing Second Acquisition in 31 Days

SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management (“RevNu”), an emerging audiology-focused revenue cycle management (“RCM”) company based in Westminster, California. “We’ve spent years building trusted relationships... Read more


Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic... Read more


Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community in Arizona. The newly acquired community offers assisted living and memory care services, and increases Pennant’s Arizona operations by 128 units. “This acquisition... Read more


Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has released a new version of the Simcyp™ Simulator for physiologically-based pharmacokinetic (PBPK) modeling. Simcyp PBPK models describe and predict the behavior of drugs in different body tissues. The latest version includes numerous advancements to further support data-driven decision-making at every stage of development. &nb... Read more


Veeva Systems Announces Research Site Clinical Trial Management System

Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system. Integration with sponsors using Veeva's Clinical Platform... Read more


HEALWELL AI Completes Acquisition of Orion Health, Becoming a Global Leader in Healthcare Data Interoperability and Artificial Intelligence

HEALWELL has acquired Auckland, New Zealand-based Orion Health Holdings Limited ("Orion Health"), a global healthcare intelligence platform providing subscription licenses and services to marquee public sector clients with data interoperability and healthcare navigation products. Orion Health1 has approximately 400 employees with offices in 11 countries globally. Its software solutions currently support over 70 public and private sector customers representing 150 million... Read more


HCA Healthcare Names Monica Cintado as Senior Vice President of Development

Joseph A. Sowell to retire after more than 15 years of service NASHVILLE, Tenn. / Apr 01, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that Monica Cintado has been appointed as senior vice president of development, effective immediately. In this role, Cintado will lead HCA Healthcare’s enterprise development strategy, overseeing mergers, acquisitions, divestitures and strategic investments.... Read more


Nutex Health Reports Fourth Quarter And Full Year 2024 Financial Results

FULL YEAR 2024 HIGHLIGHTS: TOTAL REVENUE OF $479.9 MILLION VERSUS $247.6 MILLION IN 2023, AN INCREASE OF 93.8% NET INCOME OF $52.2 MILLION VERSUS NET LOSS OF $45.8 MILLION IN 2023 DILUTED EPS OF $9.71 PER SHARE VERSUS $(10.39) PER SHARE IN 2023 EBITDA OF $98.4 MILLION VERSUS $(22.5) MILLION IN EBITDA IN 2023 ADJUSTED EBITDA OF $123.7 MILLION VERSUS $10.8 MILLION IN 2023, AN INCREASE OF 1,045.4% NET CASH FROM OPERATING ACTIVITIES OF $23.2 MILLION COMPANY BELIEVES... Read more


Progyny Expands Maternal Health Support with Addition of Doula Services

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women’s health and family building, is expanding its support throughout the maternal health journey with the addition of doula services. Currently pregnancy, childbirth, and perinatal conditions represent one of the largest shares of employer health spend in the U.S. The addition of in-person and virtual doula services to Progyny’s comprehensive maternal offerings will further its... Read more


Talkspace Expands Provider AI Toolkit with Talkcast, a New Personalized Podcast

Therapists can now produce audio episodes based on clients’ unique needs to support them between sessions 90% of clients in the initial rollout say podcast is helpful Talkcast is secure, maintains clinician-client confidentiality, and adheres to HIPAA regulations and Talkspace’s responsible AI principles NEW YORK / Mar 31, 2025 / Business Wire / Today, Talkspace (NASDAQ: TALK), a leading online behavioral healthcare company, announced the launch of Talkcast, a... Read more


The Oncology Institute Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1

CERRITOS, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today proudly announced the launch of the Florida Oncology Network. This new fully delegated network will expand access to high-quality, coordinated cancer care for Florida residents. The Florida Oncology Network includes TOI Clinics and a robust panel of value-focused... Read more


GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan

GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, is positioned to enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Kevin O’Neill, President & CEO of GE HealthCare’s Pharmaceutical Diagnostics segment, will also become President of... Read more


Ardent Health Announces Appointment of Chief Operating Officer and Senior Leadership Promotions

BRENTWOOD, Tenn. / Mar 31, 2025 / Business Wire / Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence... Read more


LifeSpeak Announces Fourth Quarter and Fiscal 2024 Results

Fiscal 2024 revenue of $48.4 million Adjusted EBITDA1 for Fiscal 2024 of $11.5 million, representing an Adjusted EBITDA Margin1 of 24% Total Number of Clients2 of 841 as at December 31, 2024 TORONTO, March 31, 2025 /CNW/ - LifeSpeak Inc. ("LifeSpeak" or the "Company") (TSX: LSPK), the leading whole-person wellbeing solution for employers, health plans and other organizations, announced today its financial and operational results for the three and twelve... Read more


GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions

GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps deliver fast, accurate diagnoses, improve operational efficiency, and enhance patient outcomes. Cardiovascular disease (CVD) is the leading cause of death and healthcare costs worldwide,ii with research projecting it could cause over 23 million deaths by 2030.iii The average number of cardiac computed tomography (CT) procedures... Read more


So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results

BEIJING, March 28, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.  Fourth Quarter 2024 Financial Highlights Total revenues were RMB369.2 million (US$50.6 million[1]), compared with... Read more


VitalHub Reports Fourth Quarter and Annual 2024 Results

Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1 million Total Revenue up 51% YoY to $20.6 million Adjusted EBITDA ⁽²⁾ up 27% YoY to $5.0 million TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) announced today it has filed its Consolidated Financial Statements and Management's Discussion and Analysis report for the year ended December 31, 2024 with the Canadian securities... Read more


ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway

The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, is now available in select U.S. markets and has been granted traditional pass-through payment status by the U.S. Centers for Medicare and Medicaid. CHICAGO / Mar 27, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz... Read more


P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results

Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast [March 27, 2025] at 4:30 PM ET HENDERSON, Nev. / Mar 27, 2025 / Business Wire / P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its... Read more


Neupath Health Reports Fourth Quarter And Year-End 2024 Results

Fourth quarter total revenue of $18.9 million, up 12% year-over-year Q4 adjusted EBITDA(1) of $0.9 million, up 18% year-over-year, and our 24th consecutive quarter of positive adjusted EBITDA. Full year adjusted EBITDA up 19% year-over-year Positive cash flows, with significant investments in our facilities to support future growth In Q1 2025 performed the first-ever injection in North America of Arthrosamid® (2.5% iPAAG) at its Mississauga, Ontario clinic In Q1 2025... Read more


HEALWELL AI Reports Record Revenue with 433% Growth in 2024, and Anticipates Closing of Transformational Orion Health Acquisition on April 1, 2025

HEALWELL achieved record annual revenue from continuing operations of approximately $39 million in fiscal 2024, an increase of 433% compared to fiscal 2023. HEALWELL achieved record quarterly revenue from continuing operations of $15.2 million in Q4-2024, 692% higher than the $1.9 million generated in Q4-2023 and 11% higher than the $13.7 million generated in Q3-2024. On December 16, 2024, HEALWELL announced the acquisition of Orion Health Holdings Limited ("Orion Health",... Read more


Alpine ENT Expands Partnership with CareCloud, Implements FrontDesk Assist to Enhance Patient Experience

SOMERSET, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and AI-powered revenue cycle management (RCM) solutions, today announced the expanded adoption of its services by Alpine Ear, Nose & Throat PC, a premier otolaryngology group based in Colorado. Following a successful RCM engagement, Alpine ENT has now implemented CareCloud FrontDesk Assist—a comprehensive front-office... Read more


Marpai Reports Fourth Quarter And Full Year 2024 Financial Results

MARPAI EXHIBITS STRONG, ONGOING FINANCIAL IMPROVEMENT TAMPA, Fla., March 26, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, which operates as a national Third-Party Administrator (TPA) through its subsidiaries and is transforming the $22 billion TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans, today announced the financial results for the fourth... Read more


Schrödinger to Present Preclinical Data at AACR Annual Meeting

Presentations include preclinical data on Wee1/Myt1 inhibitor SGR-3515 and SOS1 inhibitor SGR-4174 NEW YORK / Mar 25, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, and SGR-4174, its SOS1 inhibitor, will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25 - 30, 2025 in Chicago, IL. The SGR-3515 presentation... Read more


Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada

Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace DALLAS, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that it has entered... Read more


The Oncology Institute Announces $16.5 million Private Placement

CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today announced it has entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors for a private placement that is expected to result in gross proceeds of approximately $16.5 million, before deducting placement agent... Read more


The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025

CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2024. Recent Operational Highlights Cash flow from operations in Q4 2024 was approximately $4.2 million, due to disciplined working capital management that saw improvements... Read more


Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Provides 2028 Targets for Revenue Growth, Margin Expansion, and Free Cash Flow ST. PAUL, Minn., March 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation. "Solventum has tremendous potential, with attractive businesses, large and growing markets, and highly regarded brands. We have undertaken... Read more


GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts

The latest Invenia ABUS is designed to deliver optimal outcomes with its innovative, patient-friendly, and efficient AI-driven technology Invenia ABUS Premium features new integrated Verisound AI and AI Assistant, which ensure faster and reproducible scanning and reading with extraordinary image quality The non-invasive ultrasound technology, equipped with a novel Reverse Curve transducer and separate acquisition and reading capabilities, is built to enhance patient... Read more


Nutex Health to Present at the EDPMA Solutions Summit 2025

HOUSTON, March 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. This event will take place from March 30 to April 2 at The Broadmoor in Colorado Springs, CO. Nutex... Read more


NeueHealth Reports Fourth Quarter and Full Year 2024 Results

Delivered strongest financial performance to date in 2024, resulting from continued success of value-driven, consumer-centric care model Drove positive Adjusted EBITDA for the fourth consecutive quarter in 2024, establishing the foundation for continued strong performance in 2025 and beyond Generated significant growth to start 2025, serving 717,000 consumers, an increase of 48% compared to 2024 DORAL, Fla. / Mar 20, 2025 / Business Wire / NeueHealth, Inc. (“NeueHealth”... Read more


Kovo+ Announces LIFE Offering, Concurrent Private Placement & Warrant Extension

Vancouver, British Columbia--(Newsfile Corp. - March 19, 2025) - Kovo+ Holdings Inc. (TSXV: KOVO) (formerly Kovo HealthTech Corporation) ("Kovo" or the "Company") is pleased to announce a best efforts private placement (the "LIFE Offering") of up to 28,000,000 common shares (the "Offered Shares") of the Company at a price of $0.05 per Offered Share for aggregate gross proceeds of up to $1,400,000. Subject to compliance with applicable regulatory requirements and in... Read more


iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024

NASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the fourth quarter and full year ended December 31, 2024.  Fourth Quarter 2024 Highlights (Year-over-Year Performance): Total ARR (Annual Recurring Revenue) was $9.8&nb... Read more


GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions

Building on its 125-year legacy of medical imaging innovation and a 16-year relationship with NVIDIA, the two companies team up to advance AI-driven autonomous solutions designed to ease the growing burden on healthcare professionals. SAN JOSE, Calif. / Mar 18, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous... Read more


Marpai Accelerates Healthcare Transformation With Empara Collaboration, Launching Unified Health Engagement Platform

TAMPA, Fla., March 18, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company and a disruptor in the $22 billion Third-Party Administrator ("TPA") market, is taking decisive action to revolutionize self-funded employer health plans. Today, Marpai announces a strategic collaboration with Empara, a healthcare technology innovator, and an immediate rollout of Empara's cutting-edge Health Engagement Platform. This dynamic... Read more


HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2025 Financial Results

Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24. Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an increase of 42% compared to $195.5 million in FY24. Net income per diluted share of $1.09, an increase of 70% compared to $0.64 in FY24, with non-GAAP net income per diluted share of $3.12, an increase of 39% compared to... Read more


Sutter Health and Alignment Health Renew Long-Term, Strategic Collaboration

Agreement brings continued access to high-quality care for Alignment’s Medicare Advantage members ORANGE, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Sutter Health and Alignment Healthcare, Inc. (NASDAQ: ALHC) have renewed their agreement that provides Alignment Healthcare members with continued in-network access to Sutter’s integrated network of high-quality, comprehensive care in Northern California. This agreement applies to Alignment Healthcare members... Read more


GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures

AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab can enhance efficiency and precision care for multiple types of cardiac procedures CHICAGO / Mar 17, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex... Read more


Sonida Senior Living Announces Fourth Quarter and Full Year 2024 Results

DALLAS / Mar 17, 2025 / Business Wire / Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA) a leading owner, operator and investor of senior housing communities, today announced its results for the fourth quarter and for the full year ended December 31, 2024. “2024 was a transformative year for Sonida, highlighted by the combination of organic and inorganic growth and continued strengthening of our balance sheet.... Read more


GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement

Accomplished healthcare executives will work to drive growth, strengthen industry partnerships, and enhance pharmacy innovation at GoodRx SANTA MONICA, Calif. / Mar 17, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement, effective immediately. Aaron will... Read more


AirSculpt Technologies Reports Fourth Quarter, and Full Year Fiscal 2024 Results

MIAMI BEACH, Fla., March 14, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the fourth quarter and twelve months ended December 31, 2024. “Following a challenging 2024, I am eager to help write the next chapter for AirSculpt and focus on setting a strategy, implementing business processes and developing a culture that... Read more


The Joint Reports Fourth Quarter and Year-end 2024 Financial Results

Grew revenue from continuing operations 10% annually and 14% quarterly compared to the same period in 2023 Increased system-wide sales 9% for both the year and Q4 2024  SCOTTSDALE, Ariz., March 13, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended December 31, 2024. The results of operations of the corporate clinics business segment... Read more